ORGO
Organogenesis Holdings Inc.
$1.29
Stable Earnings Power
80%
P/Adj-EPS × Normalized Multiple
Strong
·
Conviction
Undervalued
Trading 45.9% below fair value
You pay
$1.29
Bear
$2.05
Fair
$2.39
Bull
$2.73
Bear
$2.05
+58.5%
$0.15 × 14x P/E
Fair
$2.39
+85.0%
$0.15 × 16x P/E
Bull
$2.73
+111.4%
$0.15 × 18x P/E
Adjust Assumptions
15.9x
0.15$
Key Value Driver
Normalized P/E multiple (16x base case)
Implied Market Multiple
8.6x
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above.
Average Target (6 analysts)
$2.50
Divergence from AlphaVal
4%
Summary
Applying a 16x P/E to adjusted EPS of $0.15, the base-case value is $2.39 per share.
Key Risks
- Growth DCF inappropriate — terminal value assumptions dominate
- EV/EBITDA misleading for regulated businesses where capex is mandated
- Regulatory risk is a fat tail not visible in normal multiples